Neuro-Oncology
Cerebrovascular complications of cancer
Nov. 28, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
1,25(OH)2D3--active form of vitamin D3; CAMK2g--g subunit of calcium/calmodulin-dependent protein kinase 2; CAV-1--caveolin-1; L-VGCC--L-type voltage-gated calcium channel; MAPK--mitogen-activated protein kinase; PDIA3--protein disulfide isomerase family A member 3; PI3-K--phosphatidylinositol 3-kinase; PKA--protein kinase A; PKC--protein kinase C; PLA2--phospholipase A2; PLC--phospholipase C; RXR--retinoid X receptors; SSH--sonic hedgehog; Wnt5a--ligand activating beta-catenin- independent pendent pathways; VDR--vitamin D receptor; VDRE--vitamin D response element. (Source: Lasoń W, Jantas D, Leśkiewicz M, Regulska M, Basta-Kaim A. The vitamin D receptor as a potential target for the treatment of age-related neurodegenerative diseases such as Alzheimer's and Parkinson's diseases: a narrative review. Cells 2023;12[4]:660. Creative Commons Attribution [CC BY] license, creativecommons.org/licenses/by/4.0.)